title: End of the line in sight for FDA?
abstract: The new Republican Congress is naturally antipathetic to the US Food and Drug Administration, but radical change will not be easily accomplished, which is just as well.
mesh_terms: D017277:Drug Approval; D011057:Politics; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*